F.D.A. new weight loss drug approved — Eli Lilly & Co. zep bound, when it was just a diabetes drug, was sold under the name Mounjaro. It’s a new competitor to Novo Nordisk’s wildly popular injectable Wegoby.
Although these drugs can help you lose weight quickly, it is not yet clear how much they will increase your medical costs.
Obesity is common and costly in the United States. Nearly 42% of Americans are obese, according to John Cawley, a professor of economics and public policy at Cornell University.
“And the medical costs of obesity are about $289 billion a year for adults alone, and an additional $16 billion for young people,” he said.
For now, many people taking these new weight-loss drugs only pay cash, Corey said. In other words, it is not reflected in insurance premiums.
that probably will change Because more doctors and insurance companies are starting to treat obesity as a disease rather than a lifestyle choice.
However, “if there is a fairly expensive drug for a condition that affects 40% of adults in the United States, and many of those 40% of adults are interested in taking it, it will cost a significant amount of money.” “It will be,” David said. Mr. Lind, Chief Medical Officer of the Institute for Clinical and Economic Review.
A list of these drugs can cost upwards of $1,000 per month. And even if an insurance company negotiates a lower premium and there is a rebate, if a private or government insurance company covers it, “that money is going to come from somewhere,” Lind said. “Either raise taxes and premiums, or move money to other things that also need money.”
At this time, it is too early to determine exactly what impact these weight loss drugs will have on overall health care costs.However, researchers I think there will be a major upward trend in the long term.These treatments also come at a cost, including lower rates of heart disease and diabetes.
Alison Sexton Ward said: “Treating obesity will reduce many comorbidities and reduce costs. As more drugs come to market, prices will continue to fall.” said. Scientist at the University of Southern California Schaefer Center.
Eli Lilly’s drug costs approximately 21% lower than Novo Nordiskwhich means that price competition has already begun.
There’s a lot going on in the world. For everything, Marketplace is here for you.
You use the Marketplace to analyze world events and communicate how they affect you in a factual and approachable way. We rely on your financial support to continue making that possible.
Your donation today powers the independent journalism you depend on.. For as little as $5 a month, you can help sustain our marketplace. This allows us to continue reporting on the things that matter to you.
